Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period (Q44988252)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period |
scientific article |
Statements
1 reference
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period (English)
1 reference
Steven R Deitcher
1 reference
Craig M Kessler
1 reference
Geno Merli
1 reference
James R Rigas
1 reference
Roger M Lyons
1 reference
Jawed Fareed
1 reference
ONCENOX Investigators
1 reference
1 October 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference